Patents
Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
09/2011
09/14/2011CN1642551B Inhibitors of histone deacetylase
09/14/2011CN1436191B Antitumoral ecteinascidin derivatives
09/14/2011CN102186845A S1p receptors modulators and their use thereof
09/14/2011CN102186476A Tryptophan hydroxylase inhibitors and methods of their use
09/14/2011CN102186358A Production and use of methionyl-methionine as a feed additive for fish and crustaceans
09/14/2011CN102180840A New preparation process of 6-chloro-2-hydroxyquinoxaline
09/14/2011CN101723907B O-dicyano-acenaphtho pyrazine compound and anti-tumor application thereof
09/14/2011CN101602737B Benzenesulfonyl quinoxaline compound and preparation method and application thereof
09/13/2011US8017773 Cyclohexyl sulfonamide derivatives
09/13/2011US8017771 Process for preparing acyclic HCV protease inhibitors
09/13/2011US8017617 Amidine-containing compounds useful as muscarinic receptor antagonists
09/13/2011US8017612 Piperazine compound and use thereof as a HCV polymerase inhibitor
09/13/2011CA2509981C Hetero substitued sodium channel blockers
09/13/2011CA2396937C Amides, useful in the inhibition of il-8-induced chemotaxis of neutrophils
09/09/2011WO2010123956A3 2,5-disubstituted arylsulfonamide ccr3 antagonists
09/08/2011US20110218208 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases
09/08/2011US20110218200 Methods of treating amyloid disease using analogs of 1-(4-nitrophenyl) piperazine
09/08/2011US20110214810 Hydroxyaldimine-containing polyurethane composition
09/07/2011CN1787817B 免疫抑制剂化合物及组合物 Immunosuppressive compounds and compositions
09/07/2011CN1777592B Quinoxaline derivatives, and organic semiconductor devices, electroluminescent devices and electronic appliances, made by using the derivatives
09/07/2011CN102177153A Compositions and methods for treating alcohol use disorders, pain and other diseases
09/07/2011CN101565409B Piperazidine or homopiperazine oxalyl hydrazine class compound, preparation and use thereof
09/06/2011US8013152 Biphenyl compounds useful as muscarinic receptor antagonists
09/06/2011US8012988 N-(2,4-dioxo-6-(tetrahydrofuran-2-yl)-7-(trifluoromethyl)-1,4-dihydro-2H-quinazolin-3-yl)methanesulfonamide
09/06/2011US8012982 Modulators of HCV replication
09/06/2011US8012975 Antitumoral analogs of ET-743
09/01/2011WO2011104127A1 Latent acids and their use
09/01/2011WO2011103932A1 A process for the preparation of substituted prolyl peptides and similar peptidomimetics
09/01/2011WO2010141550A3 11beta-hydroxysteroid dehydrogenase type 1 (11-beta hsd1) inhibitors
09/01/2011US20110212971 Diketo fused azolopiperidines and azolopiperazines as anti-hiv agents
09/01/2011US20110212969 Substituted hydroxamic acids and uses thereof
09/01/2011US20110212968 Phenethylamide derivatives and their heterocyclic analogues
09/01/2011US20110212080 Urea derivatives as antibacterial agents
09/01/2011CA2791045A1 A process for the preparation of substituted prolyl peptides and similar peptidomimetics
08/2011
08/31/2011CN101735158B Preparation method of 2,3-dimercapto-6-methylquinoxaline
08/31/2011CN101638352B Aryl-replaced nitrogen heterocyclic compound preparation method
08/30/2011US8008494 2-(4-{4-[N'-(3,5-diamino-6-chloropyrazine-2-carbonyl)guanidino]-butyl}phenoxy)-N-(3-dimethylaminopropyl)acetamide dimethanesulfonate; promoting hydration of mucosal surfaces; Sjogren's disease, esophagitis, pneumonia, asthma, otitis, constipation, chronic diverticulitis, rhinosinusitis
08/30/2011US8008492 Compounds that act as a vehicle for delivery through the blood-brain barrier and charge delivery vehicle constructions
08/30/2011US8008489 Quinoxaline derivative, and light-emitting element, light-emitting device, electronic device using the quinoxaline derivative
08/30/2011US8008306 Quinoline compounds
08/30/2011US8008300 Therapeutic agents useful for treating pain
08/30/2011US8008290 Compounds
08/30/2011CA2531165C A method for the preparation of enantiomerically pure mirtazapine
08/25/2011WO2011102794A1 Processes for making cyclopropyl amide derivatives and intermediates associated therewith
08/25/2011WO2011101810A1 Use of indanthrene compounds in organic photovoltaics
08/25/2011US20110207926 Novel dihydrotriazine derivative
08/25/2011US20110207745 Solid forms of 4--n,n-diethylbenzamide, compositions thereof, and uses therewith
08/25/2011US20110207739 Novel 1, 2-Disubstituted Amido-anthraquinone Derivatives, Preparation Method and application thereof
08/25/2011US20110207730 Ion channel modulating compounds and uses thereof
08/25/2011US20110207712 Phosphatidylinositol 3-Kinase Inhibitors And Methods Of Their Use
08/25/2011US20110207198 Compositions and methods for inhibiting mmset
08/25/2011US20110203649 Use of indanthrene compounds in organic photovoltaics
08/25/2011CA2790040A1 Processes for making cyclopropyl amide derivatives and intermediates associated therewith
08/24/2011EP1951687B1 N-hydroxyamide derivatives and use thereof
08/24/2011EP1485353B1 New inhibitors of histone deacetylase
08/24/2011CN102164896A Phenethylamide derivatives and their heterocyclic analogues
08/24/2011CN101723908B Method for preparing di-nitrogen quinoxalin compound
08/23/2011US8003799 Picolinic acid derivatives and their use as fungicides
08/23/2011US8003791 Boronic ester and acid compounds, synthesis and uses
08/23/2011US8003648 Heterocyclic GPR40 modulators
08/23/2011US8003645 type II diabetes; 6-Ethyl-N,N'-bis(3-hydroxyphenyl)-1,3,5-triazine-2,4-diamine; suppress the fall in MTT reduction capacity by beta -amyloid protein; inhibit impairment of long-term potentiation of hippocampal nerve cells, pyrimidine or 1,3,5 triazine derivatives
08/18/2011WO2011077043A3 Phenol derivatives and pharmaceutical or cosmetic use thereof
08/18/2011WO2011046946A3 Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus
08/18/2011US20110201625 Organic Comopunds
08/18/2011US20110201622 Solid Forms Comprising A Cyclopropyl Amide Derivative
08/18/2011US20110201603 Novel Acylaminobenzamide Derivatives
08/17/2011EP2357173A1 New alkyne compounds with MCH-antagonistic activity and medicaments containing them
08/17/2011EP2356109A2 Compositions and methods for treating alcohol use disorders, pain and other diseases
08/17/2011EP2356094A1 Novel phenyl amide or pyridil amide derivatives and their use as gpbar1 agonists
08/17/2011EP2188268B1 Substituted piperazinyl pyrazines and pyridines as 5-ht7 receptor antagonists
08/17/2011EP2094656B1 P<0}{0pyrrol derivatives, preparation and use of the same in therapy<0}
08/17/2011EP1485360B1 Sodium channel blockers
08/17/2011CN102159556A 1,4-benzoxazine compounds and derivatives thereof as therapeutic drugs for the treatment of neurodegenerative conditions
08/17/2011CN102159547A Heterocyclic carboxamide compounds
08/16/2011US7999086 Method of conditioning azo pigments containing carboxylic ester groups
08/16/2011US7998965 Glutamate aggrecanase inhibitors
08/16/2011US7998964 hydroxy((2S)-2-{[4-(4-methoxyphenyl)piperazin-1-yl]carbonyl}-4-methylpentyl)formamide ; for treatment and/or prevention of disorders related to autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative disorders, stroke, cancer, pre-term labor, endometriosis
08/16/2011CA2590261C Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases and conditions
08/16/2011CA2458009C Piperazinone compounds as anti-tumor and anti-cancer agents and methods of treatment
08/11/2011WO2011095885A1 An improved process for the preparation of piperaquine
08/11/2011WO2011094890A1 Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators
08/11/2011WO2010143170A3 Compounds useful for treating premature aging and in particular progeria
08/11/2011US20110196175 Hydroxylation of Beta-Dicarbonyls with Zirconium Catalysts
08/11/2011US20110195978 Compounds for treatment of alzheimer's disease
08/11/2011US20110195977 Acrylamido derivatives useful as inhibitors of the mitochondrial permeability transition
08/11/2011US20110195973 Cyclic substituted pyrazinoylguanidine sodium channel blockers possessing beta agonist activity
08/11/2011US20110195963 Novel carbamoyloxy arylalkanoyl arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound
08/11/2011US20110195242 Aldehydes containing hydroxl groups
08/10/2011EP2352725A1 Quinoxaline-based lxr modulators
08/10/2011EP2352724A2 Aryl guanidine f1f0-atpase inhibitors and related methods
08/10/2011EP2197854B1 A new class of histone deacetylase inhibitors
08/10/2011CN1551878B 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
08/10/2011CN102149714A Novel tricyclic derivatives, process for the preparation thereof and pharmaceutical compositions containing same
08/10/2011CN102149690A Glucocorticoid receptor agonist comprising novel 1,2,3,4-tetrahydroquinoxaline derivative containing phenyl group having sulfonic acid ester structure introduced therein as substituent
08/10/2011CN102146053A 2-phenoxy- and 2-phenylsulfonamide derivatives with CCR3 antagonistic activity for the treatment of inflammatory or immunological disorders
08/09/2011US7994423 Charge-transport materials, methods of fabrication thereof, and methods of use thereof
08/09/2011US7994167 Pentafluorosulphanyl-substituted compound and its use for producing medicaments
08/09/2011US7994093 Heterocyclocarboxamide derivatives
08/09/2011US7993761 Quinoxaline derivative, and light-emitting element, light-emitting device, and electronic device using the same
08/09/2011CA2431083C Inflammatory cytokine release inhibitor
1 ... 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 ... 187